in8bio / A novel off-the-shelf treatment using multiple modes of

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://in8bio.com/sitemap_index.xml # --------------------------- # END YOAST

Meta Tags

Title	A novel off-the-shelf treatment using multiple modes of
Description	The Next Generation of Cellular IN8bio uses genetically modified gamma-delta (γδ) T cells to address the challenges with cold, low mutation
Keywords	N/A

Server Information

WebSite	in8bio.com
Host IP	35.227.47.113
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

in8bio.com Valuation

US$8,892,953

Last updated: 2023-04-27 06:02:47

in8bio.com has Semrush global rank of 1,190,190. in8bio.com has an estimated worth of US$ 8,892,953, based on its estimated Ads revenue. in8bio.com receives approximately 1,026,110 unique visitors each day. Its web server is located in United States, with IP address 35.227.47.113. According to SiteAdvisor, in8bio.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$8,892,953
Daily Ads Revenue	US$8,209
Monthly Ads Revenue	US$246,267
Yearly Ads Revenue	US$2,955,197
Daily Unique Visitors	68,408
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
in8bio.com.	A	3599	IP: 35.227.47.113
in8bio.com.	NS	21600	NS Record: ns-cloud-b3.googledomains.com.
in8bio.com.	NS	21600	NS Record: ns-cloud-b4.googledomains.com.
in8bio.com.	NS	21600	NS Record: ns-cloud-b1.googledomains.com.
in8bio.com.	NS	21600	NS Record: ns-cloud-b2.googledomains.com.
in8bio.com.	MX	3600	MX Record: 1 aspmx.l.google.com.
in8bio.com.	MX	3600	MX Record: 10 alt3.aspmx.l.google.com.
in8bio.com.	MX	3600	MX Record: 10 alt4.aspmx.l.google.com.
in8bio.com.	MX	3600	MX Record: 5 alt1.aspmx.l.google.com.
in8bio.com.	MX	3600	MX Record: 5 alt2.aspmx.l.google.com.
in8bio.com.	TXT	3600	TXT Record: v=spf1 include:_spf.google.com ~all
in8bio.com.	TXT	3600	TXT Record: google-siteverification= vcJ5Pro3 - PnIGKaWb2xTsjgoFh q6nQtVW8GmhHXrod k

HtmlToTextCheckTime:2023-04-27 06:02:47

About Mission Management Board Scientific Advisors Technology Pipeline Investors & News Contact Search https://in8bio.com/wp-content/uploads/2020/09/IN8bio_header-smaller_size_5.mp4 The Next Generation of Cellular Therapies Our Company A Novel Approach to Cancer Cell Therapy We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies for the treatment of cancer. Our platform employs allogeneic, autologous and genetically modified approaches to develop novel cell therapies, which are designed to effectively identify and eradicate tumor cells. We are one of the most advanced gamma-delta T cell companies and the first to bring genetically modified gamma-delta T cells into the clinic. Our lead product candidates are currently in Phase 1 clinical trials: INB-200, for the treatment of newly diagnosed glioblastoma, or GBM, and INB-100, for the treatment of patients with leukemia that are undergoing

HTTP Headers

HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Wed, 20 Oct 2021 11:53:15 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Keep-Alive: timeout=20
Location: https://in8bio.com/
Content-Security-Policy: upgrade-insecure-requests

HTTP/2 200 
server: nginx
date: Wed, 20 Oct 2021 11:53:15 GMT
content-type: text/html; charset=UTF-8
content-length: 44194
vary: Accept-Encoding
vary: Accept-Encoding
set-cookie: uncode_privacy[consent_types]=%5B%5D; expires=Thu, 20-Oct-2022 11:39:53 GMT; Max-Age=31536000; path=/; secure; SameSite=Strict
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-powered-by: WP Engine
x-cacheable: SHORT
vary: Accept-Encoding,Cookie
cache-control: max-age=600, must-revalidate
x-cache: HIT: 1
x-cache-group: normal
accept-ranges: bytes
content-security-policy: upgrade-insecure-requests

in8bio.com Whois Information

Domain Name: IN8BIO.COM
Registry Domain ID: 2549180316_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.google.com
Registrar URL: http://domains.google.com
Updated Date: 2021-05-04T14:32:03Z
Creation Date: 2020-07-28T16:54:34Z
Registry Expiry Date: 2030-07-28T16:54:34Z
Registrar: Google LLC
Registrar IANA ID: 895
Registrar Abuse Contact Email: registrar-abuse@google.com
Registrar Abuse Contact Phone: +1.8772376466
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS-CLOUD-B1.GOOGLEDOMAINS.COM
Name Server: NS-CLOUD-B2.GOOGLEDOMAINS.COM
Name Server: NS-CLOUD-B3.GOOGLEDOMAINS.COM
Name Server: NS-CLOUD-B4.GOOGLEDOMAINS.COM
DNSSEC: signedDelegation
DNSSEC DS Data: 57940 8 2 A2520DDEB6F44ABAD2BBC537C2142DC1B788D13CC5E8BC4EEA74E5A6FE24E1F9
>>> Last update of whois database: 2021-09-09T00:51:02Z <<<

in8bio.com valuation and analysis